Department of Oncology, The First Affiliated Hospital of Wenzhou Medical College, No. 2 Fuxue Lane, Wenzhou, Zhejiang, China.
World J Surg Oncol. 2012 May 19;10:67. doi: 10.1186/1477-7819-10-67.
The optimal resection extent for papillary thyroid microcarcinoma (PTMC) remains controversial. The objective of the study was to investigate risk factors of bilateral PTMC and central lymph node metastasis (CLNM) to guide surgical strategies for PTMC patients.
We retrospectively reviewed 211 PTMC patients who underwent total thyroidectomy (TT) and 122 clinical lymph node-negative (cN0) cases that underwent prophylactic central lymph node dissection (CLND) between 2010 and 2011. The frequency, pattern, and predictive factors for bilateral PTMC and CLNM in these patients were studied using univariate and multivariate analysis with respect to the following variables: age, gender, extrathyroidal extension (ETE), T stage, with Hashimoto thyroiditis (HT), tumor size and multifocality based on final pathology, and preoperative evaluation using ultrasonography (US).
Fifty-four of 211 (25.6%) patients had bilateral PTMC. In multivariate analysis, multifocality (P < 0.001, OR = 23.900) and tumor size ≥7 mm (P = 0.014, OR = 2.398) based on US were independent predictive factors for bilateral PTMC which was also independently associated with multifocality (P < 0.001, OR = 29.657) and tumor size ≥7 mm (P = 0.005, OR = 2.863) based on final pathology. Among 122 cN0 patients who underwent prophylactic CLND, we found 49.2% of patients had CLNM. CLNM was independently associated with men, age <50 years and tumor size ≥7 mm based on final pathology or preoperative US.
TT should be considered for PTMC patients who are found multifocality and tumor size ≥7 mm based on preoperative US. CLND need be considered in cN0 patients who are men, aged <50 years or tumor size ≥7 mm based on preoperative US.
甲状腺微小乳头状癌(PTMC)的最佳切除范围仍存在争议。本研究旨在探讨双侧 PTMC 和中央淋巴结转移(CLNM)的危险因素,以指导 PTMC 患者的手术策略。
我们回顾性分析了 2010 年至 2011 年间行全甲状腺切除术(TT)的 211 例 PTMC 患者和 122 例临床淋巴结阴性(cN0)行预防性中央淋巴结清扫术(CLND)的患者。使用单变量和多变量分析,研究这些患者双侧 PTMC 和 CLNM 的频率、模式和预测因素,变量包括年龄、性别、甲状腺外侵犯(ETE)、T 分期、桥本甲状腺炎(HT)、肿瘤大小和多灶性基于最终病理,以及术前超声(US)检查。
211 例患者中 54 例(25.6%)为双侧 PTMC。多变量分析显示,多灶性(P<0.001,OR=23.900)和 US 检查肿瘤大小≥7mm(P=0.014,OR=2.398)是双侧 PTMC 的独立预测因素,并且与多灶性(P<0.001,OR=29.657)和肿瘤大小≥7mm(P=0.005,OR=2.863)均相关。在 122 例行预防性 CLND 的 cN0 患者中,我们发现 49.2%的患者有 CLNM。CLNM 与男性、年龄<50 岁和肿瘤大小≥7mm(基于最终病理或术前 US)相关。
对于术前 US 显示多灶性和肿瘤大小≥7mm 的 PTMC 患者,应考虑行 TT。对于术前 US 显示为男性、年龄<50 岁或肿瘤大小≥7mm 的 cN0 患者,应考虑行 CLND。